Carregant...

Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates

Severe noninfectious adverse events (AEs) and transmission of pathogens by plasma-derived protein concentrates from the very beginning of their clinical use were threats for recipients (see Chap. 10.1007/978-3-319-68038-5_11 for additional information). “Standard IgG” preparations were the first ava...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antibody Therapy
Autor principal: Späth, Peter J.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7122986/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-3-319-68038-5_12
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!